222 related articles for article (PubMed ID: 11525955)
1. Cutaneous ulceration as a sign of methotrexate toxicity.
Del Pozo J; Martínez W; García-Silva J; Almagro M; Peña-Penabad C; Fonseca E
Eur J Dermatol; 2001; 11(5):450-2. PubMed ID: 11525955
[TBL] [Abstract][Full Text] [Related]
2. Early-onset pancytopenia and skin ulcer following low-dose methotrexate therapy.
Hocaoglu N; Atilla R; Onen F; Tuncok Y
Hum Exp Toxicol; 2008 Jul; 27(7):585-9. PubMed ID: 18829735
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous ulceration with methotrexate.
Prescrire Int; 2003 Apr; 12(64):59-60. PubMed ID: 12674119
[TBL] [Abstract][Full Text] [Related]
4. Focal skin toxicity related to methotrexate sparing psoriatic plaques.
Truchuelo T; Alcántara J; Moreno C; Vano-Galván S; Jaén P
Dermatol Online J; 2010 Jun; 16(6):16. PubMed ID: 20579471
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous ulceration: an unusual sign of methotrexate toxicity--first report in a patient without psoriasis.
Ben-Amitai D; Hodak E; David M
Ann Pharmacother; 1998 Jun; 32(6):651-3. PubMed ID: 9640483
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous erosions: a herald for impending pancytopenia in methotrexate toxicity.
Shiver MB; Hall LA; Conner KB; Brown GE; Cheung WL; Wirges ML
Dermatol Online J; 2014 Jul; 20(7):. PubMed ID: 25046458
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in the thymidylate synthase and methylenetetrahydrofolate reductase genes and sensitivity to the low-dose methotrexate therapy in patients with rheumatoid arthritis.
Kumagai K; Hiyama K; Oyama T; Maeda H; Kohno N
Int J Mol Med; 2003 May; 11(5):593-600. PubMed ID: 12684695
[TBL] [Abstract][Full Text] [Related]
8. Acute methotrexate toxicity seen as plaque psoriasis ulceration and necrosis: A diagnostic clue.
Fridlington JL; Tripple JW; Reichenberg JS; Hall CS; Diven DG
Dermatol Online J; 2011 Nov; 17(11):2. PubMed ID: 22136858
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes.
Wessels JA; de Vries-Bouwstra JK; Heijmans BT; Slagboom PE; Goekoop-Ruiterman YP; Allaart CF; Kerstens PJ; van Zeben D; Breedveld FC; Dijkmans BA; Huizinga TW; Guchelaar HJ
Arthritis Rheum; 2006 Apr; 54(4):1087-95. PubMed ID: 16572443
[TBL] [Abstract][Full Text] [Related]
10. Low dose treatment with methotrexate-adverse drug reactions survey.
Getov I; Dimitrova Z; Petkova V
Boll Chim Farm; 2000; 139(4):153-8. PubMed ID: 11059096
[TBL] [Abstract][Full Text] [Related]
11. 2756GG genotype of methionine synthase reductase gene is more prevalent in rheumatoid arthritis patients treated with methotrexate and is associated with methotrexate-induced nodulosis.
Berkun Y; Abou Atta I; Rubinow A; Orbach H; Levartovsky D; Aamar S; Arbel O; Dresner-Pollak R; Friedman G; Ben-Yehuda A
J Rheumatol; 2007 Aug; 34(8):1664-9. PubMed ID: 17611986
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate toxicity presenting as ulcerated psoriatic plaques.
Wong SM; Chong YT; Thevarajah S; Baba R
Australas J Dermatol; 2012 Feb; 53(1):81-3. PubMed ID: 22309341
[TBL] [Abstract][Full Text] [Related]
13. Two patterns of skin ulceration induced by methotrexate in patients with psoriasis.
Lawrence CM; Dahl MG
J Am Acad Dermatol; 1984 Dec; 11(6):1059-65. PubMed ID: 6512051
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate toxicity presenting as cutaneous ulcerations on psoriatic plaques.
Koçak AY; Koçak O; Aslan F; Tektaş M
Cutan Ocul Toxicol; 2013 Oct; 32(4):333-5. PubMed ID: 23537374
[TBL] [Abstract][Full Text] [Related]
15. Leukocytoclastic vasculitis induced by low-dose methotrexate: in vitro evidence for an immunologic mechanism.
Halevy S; Giryes H; Avinoach I; Livni E; Sukenik S
J Eur Acad Dermatol Venereol; 1998 Jan; 10(1):81-5. PubMed ID: 9552765
[TBL] [Abstract][Full Text] [Related]
16. Risk factors associated with the cumulative survival of low-dose methotrexate in 273 Japanese patients with rheumatoid arthritis.
Ideguchi H; Ohno S; Ishigatsubo Y
J Clin Rheumatol; 2007 Apr; 13(2):73-8. PubMed ID: 17414533
[TBL] [Abstract][Full Text] [Related]
17. IgG and IgM anticardiolipin antibodies following treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis.
Visvanathan S; Wagner C; Smolen J; St Clair EW; Hegedus R; Baker D; Keenan G
Arthritis Rheum; 2006 Sep; 54(9):2840-4. PubMed ID: 16948115
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous ulceration caused by methotrexate.
Kazlow DW; Federgrun D; Kurtin S; Lebwohl MG
J Am Acad Dermatol; 2003 Aug; 49(2 Suppl Case Reports):S197-8. PubMed ID: 12894123
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of MTHFR polymorphism screening by polymerase chain reaction in Korean patients with rheumatoid arthritis receiving methotrexate.
Kim SK; Jun JB; El-Sohemy A; Bae SC
J Rheumatol; 2006 Jul; 33(7):1266-74. PubMed ID: 16758511
[TBL] [Abstract][Full Text] [Related]
20. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
